Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis

por Ren, Yuan-Rong, Jin, Yong-Dong, Zhang, Zhi-Hui, Li, Li, Wu, Ping
Publicado 2015

Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001)

por Song, Bo, Hu, Hai, Zhang, Li, Ye, Su-Juan, Jin, Yong-Dong, Shang, Chang-Ling, Zhang, Jun, Sun, Hao, Zhang, Ke, Yi, Bo, Han, Yun-Wei, Yan, Jin
Publicado 2023